Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
20-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #28229
advertisement
Chen Y
25
Showing records 1 to 25 |
Display all abstracts from
Chen Y
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Gong B
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Liu Y
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Wang L; Rouse B
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhang H
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wang Y; Chen Y
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang L
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Marks-Anglin A
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Chen Y
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Duan R
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Fang X
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Shi Y
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wen T
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Shi Q
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Xiao M
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Tam PO
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Quach K
Journal of Clinical Epidemiology
2019; 114: 84-94
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Chen S
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhu X
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Chen Y; Cameron C
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang Y
Genetics in Medicine
2019; 21: 2345-2354
81413
Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Zhang X
Investigative Ophthalmology and Visual Science
2019; 60: 2925-2934
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Schmid CH
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Lei B
Genetics in Medicine
2019; 21: 2345-2354
81315
Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Li T
Journal of Clinical Epidemiology
2019; 114: 84-94
80886
Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Sundaresan P; Li X; Jiang L; Lin Y; Lu F; Chen L; Li Y; Leung CK; Guo X; Zhang S; Huang G; Wu Y; Zhou T; Shuai P; Tham CC; Weisschuh N; Krishnadas SR; Mardin C; Reis A; Yang J
Genetics in Medicine
2019; 21: 2345-2354
Issue
20-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement